GP
ACAD icon

Girard Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Girard Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,020
Closed -$21K – 242
2018
Q3 		$21K Buy
+1,020
New +$21K ﹤0.01% 590